Global Cell Analysis Markets, 2014-2019 & 2020-2025

Dublin, Sept. 15, 2020 (GLOBE NEWSWIRE) -- The "Cell Analysis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been added to's offering.

The global cell analysis market grew at a CAGR of around 8% during 2014-2019.

Cell analysis is typically done to understand population heterogeneity, identifying minority sub-populations of interest, as well as discovering unique characteristics of individual cells. It further aids in gene and protein identification, and epigenomics, as well as understanding the factors that underlie cell health, proliferation and death.

Cell analysis is utilized across academic and research laboratories, hospitals, and biotechnology and pharmaceutical, for studying stem cells, immunology, neurology, non-invasive prenatal diagnosis and in-vitro fertilization.

Furthermore, the rising prevalence of chronic diseases, along with the development of advanced therapies for the treatment of cancer, are encouraging technological advancements in cell analysis. For instance, Fluidigm Corporation, a US-based company, announced the introduction of a REAP-seq (RNA expression and protein sequencing) that will help researchers to understand the mechanisms of cancer progression and immune response.

The increasing investments by governments of several nations in extensive research and development (R&D) activities in the life science sector are acting as another major growth-inducing factor. Other factors, such as the rapid expansion of the biopharmaceutical and biotechnological companies and significant growth in the healthcare industry, are expected to further create a positive outlook for the market.

Key Questions Answered in This Report:

  • How has the global cell analysis market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What has been the impact of COVID-19 on the global cell analysis market?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the analysis type?
  • What is the breakup of the market based on the technique?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the market?
  • What is the structure of the global cell analysis market and who are the key players?
  • What is the degree of competition in the market?

Key Topics Covered:

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global Cell Analysis Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Analysis Type
6.1 Flow Cytometry Products
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 qPCR Products
6.3 Cell Microarrays
6.4 Microscopes
6.5 Spectrophotometers
6.6 Cell Counters
6.7 HCS Systems
6.8 Others

7 Market Breakup by Process
7.1 Cell Identification
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Cell Viability
7.3 Cell Signaling Pathways/Signal Transduction
7.4 Cell Proliferation
7.5 Cell Counting and Quality Control
7.6 Cell Interaction
7.7 Target Identification and Validation
7.8 Single-Cell Analysis
7.9 Others

8 Market Breakup by Techniques
8.1 Molecular Approaches
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Image-Based Approaches

9 Market Breakup by End-User
9.1 Pharmaceutical and Biotechnology Companies and CROs
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Hospitals and Diagnostic Laboratories
9.3 Research Institutes
9.4 Cell Culture Collection Repositories
9.5 Others

10 Market Breakup by Region

11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes

14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players

  • Agilent Technologies Inc.
  • BD Biosciences
  • Bio-RAD Laboratories Inc.
  • Danaher Corporation
  • Illumina Inc.
  • Merck KGaA
  • Miltenyi Biotec
  • Olympus Corporation
  • PerkinElmer Inc.
  • Promega Corporation
  • Sysmex Corporation
  • Thermo Fisher Scientific

For more information about this report visit

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.


Contact Data